Impax Laboratories, Inc. News Headlines

Get IPXL Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha

Adamas' Lead Drug Targets Parkinson's Dyskinesia
2/3/2015 5:53:00 PM - Seeking Alpha

Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog
1/28/2015 6:10:00 AM - Investopedia

Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog
1/27/2015 6:00:00 AM - Investopedia

PFE Cuts Vaccine Price, CVM On Track, BABY Takes New Step, IPXL On A High
1/27/2015 4:42:00 AM - RTT News

New Drug Approvals - The Month That Was
1/26/2015 10:27:00 AM - RTT News

Impax: FDA Approves Generic Lamictal ODT Antiepileptic Drug - Quick Facts
1/26/2015 8:20:00 AM - RTT News

Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog
1/26/2015 4:00:00 AM - Investopedia

Bayer Announces Updates to European Label of Xarelto - Analyst Blog
1/21/2015 6:17:00 AM - Investopedia

Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog
1/21/2015 6:13:00 AM - Investopedia

Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
1/21/2015 6:08:00 AM - Investopedia

Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog
1/21/2015 4:00:00 AM - Investopedia

Actavis/Gedeon Richter Present Schizophrenia Drug Data - Analyst Blog
1/20/2015 4:30:00 AM - Investopedia

Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog
1/13/2015 4:00:00 AM - Investopedia

Update: Impax Laboratories' Reversal Of Misfortune
1/10/2015 8:07:00 AM - Seeking Alpha

Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
1/9/2015 4:39:00 AM - Investopedia

Impax Laboratories Inc. (IPXL) Has Broken Out To A New High After FDA Approval
1/8/2015 9:40:00 AM - RTT News

Impax Wins FDA Nod For RYTARY ER Capsules For Treatment Of Parkinson''s Disease
1/8/2015 8:18:00 AM - RTT News

NeuroDerm Skyrockets on Parkinson's Disease Study Data - Analyst Blog
12/31/2014 3:50:00 AM - Investopedia

An Upcoming Catalyst At Impax Laboratories
12/18/2014 11:57:00 AM - Seeking Alpha

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 AM - Investopedia

Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha

The Characteristics Of High-Return Stocks
8/8/2014 7:25:00 AM - Seeking Alpha

Today In SA PRO: Monday, June 23
6/24/2014 5:00:00 AM - Seeking Alpha

6 Stocks With High Days-To-Cover Ratios That Could Trap The Bears
6/10/2014 4:49:00 AM - Seeking Alpha